Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joseph Biederman, M.D.

Co-Author

This page shows the publications co-authored by Joseph Biederman and Gagan Joshi.
Connection Strength

11.948
  1. Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature. J Psychopharmacol. 2021 03; 35(3):203-210.
    View in: PubMed
    Score: 0.938
  2. A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder. World J Biol Psychiatry. 2020 04; 21(4):274-290.
    View in: PubMed
    Score: 0.874
  3. Predictive utility of autistic traits in youth with ADHD: a controlled 10-year longitudinal follow-up study. Eur Child Adolesc Psychiatry. 2020 Jun; 29(6):791-801.
    View in: PubMed
    Score: 0.856
  4. High Risk for Severe Emotional Dysregulation in Psychiatrically Referred Youth with Autism Spectrum Disorder: A Controlled Study. J Autism Dev Disord. 2018 Sep; 48(9):3101-3115.
    View in: PubMed
    Score: 0.799
  5. A Prospective Open-Label Trial of Memantine Hydrochloride for the Treatment of Social Deficits in Intellectually Capable Adults With Autism Spectrum Disorder. J Clin Psychopharmacol. 2016 Jun; 36(3):262-71.
    View in: PubMed
    Score: 0.684
  6. Examining the clinical correlates of autism spectrum disorder in youth by ascertainment source. J Autism Dev Disord. 2014 Sep; 44(9):2117-26.
    View in: PubMed
    Score: 0.606
  7. Symptom Profile of ADHD in Youth With High-Functioning Autism Spectrum Disorder: A Comparative Study in Psychiatrically Referred Populations. J Atten Disord. 2017 Aug; 21(10):846-855.
    View in: PubMed
    Score: 0.602
  8. Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: a comparative study. J Autism Dev Disord. 2013 Jun; 43(6):1314-25.
    View in: PubMed
    Score: 0.555
  9. A prospective open-label trial of paliperidone monotherapy for the treatment of bipolar spectrum disorders in children and adolescents. Psychopharmacology (Berl). 2013 Jun; 227(3):449-58.
    View in: PubMed
    Score: 0.544
  10. Discriminant and concurrent validity of a simplified DSM-based structured diagnostic instrument for the assessment of autism spectrum disorders in youth and young adults. BMC Psychiatry. 2011 Dec 30; 11:204.
    View in: PubMed
    Score: 0.503
  11. A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder. J Affect Disord. 2012 Feb; 136(3):1143-53.
    View in: PubMed
    Score: 0.497
  12. The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population. J Autism Dev Disord. 2010 Nov; 40(11):1361-70.
    View in: PubMed
    Score: 0.464
  13. Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder. Bipolar Disord. 2010 Mar; 12(2):196-204.
    View in: PubMed
    Score: 0.443
  14. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. J Child Adolesc Psychopharmacol. 2010 Feb; 20(1):7-14.
    View in: PubMed
    Score: 0.441
  15. Decreased risk for substance use disorders in individuals with high-functioning autism spectrum disorder. Eur Child Adolesc Psychiatry. 2021 Aug 07.
    View in: PubMed
    Score: 0.245
  16. Functional Alterations Associated with Structural Abnormalities in Adults with High-Functioning Autism Spectrum Disorder. Brain Connect. 2020 09; 10(7):368-376.
    View in: PubMed
    Score: 0.228
  17. A Retrospective Chart Review of Buspirone for the Treatment of Anxiety in Psychiatrically Referred Youth with High-Functioning Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2019 02; 29(1):28-33.
    View in: PubMed
    Score: 0.203
  18. Further evidence of high level of persistence of pediatric bipolar-I disorder from childhood onto young adulthood: a five-year follow up. Scand J Child Adolesc Psychiatr Psychol. 2018; 6(1):40-51.
    View in: PubMed
    Score: 0.198
  19. Integration and Segregation of Default Mode Network Resting-State Functional Connectivity in Transition-Age Males with High-Functioning Autism Spectrum Disorder: A Proof-of-Concept Study. Brain Connect. 2017 11; 7(9):558-573.
    View in: PubMed
    Score: 0.189
  20. Prescribing Patterns in a Psychiatrically Referred Sample of Youth With Autism Spectrum Disorder. J Clin Psychiatry. 2017 Nov/Dec; 78(9):e1276-e1283.
    View in: PubMed
    Score: 0.189
  21. A study of the neuropsychological correlates in adults with high functioning autism spectrum disorders. Acta Neuropsychiatr. 2016 Oct; 28(5):286-95.
    View in: PubMed
    Score: 0.169
  22. Brief report: examining driving behavior in young adults with high functioning autism spectrum disorders: a pilot study using a driving simulation paradigm. J Autism Dev Disord. 2013 Sep; 43(9):2211-7.
    View in: PubMed
    Score: 0.141
  23. Autistic traits in children with and without ADHD. Pediatrics. 2013 Sep; 132(3):e612-22.
    View in: PubMed
    Score: 0.141
  24. Can pediatric bipolar-I disorder be diagnosed in the context of posttraumatic stress disorder? A familial risk analysis. Psychiatry Res. 2013 Aug 15; 208(3):215-24.
    View in: PubMed
    Score: 0.139
  25. Examining the comorbidity of bipolar disorder and autism spectrum disorders: a large controlled analysis of phenotypic and familial correlates in a referred population of youth with bipolar I disorder with and without autism spectrum disorders. J Clin Psychiatry. 2013 Jun; 74(6):578-86.
    View in: PubMed
    Score: 0.139
  26. Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4T. Eur Arch Psychiatry Clin Neurosci. 2013 Aug; 263(5):379-84.
    View in: PubMed
    Score: 0.132
  27. Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. J Pediatr. 2013 Jan; 162(1):22-7.e2.
    View in: PubMed
    Score: 0.131
  28. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry. 2011 Jun; 50(6):543-53.
    View in: PubMed
    Score: 0.120
  29. Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder. CNS Neurosci Ther. 2012 Jan; 18(1):28-33.
    View in: PubMed
    Score: 0.117
  30. Child behavior checklist clinical scales discriminate referred youth with autism spectrum disorder: a preliminary study. J Dev Behav Pediatr. 2010 Jul-Aug; 31(6):485-90.
    View in: PubMed
    Score: 0.113
  31. A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neurosci Ther. 2010 Apr; 16(2):91-102.
    View in: PubMed
    Score: 0.111
  32. Clinical characteristics of comorbid obsessive-compulsive disorder and bipolar disorder in children and adolescents. Bipolar Disord. 2010 Mar; 12(2):185-95.
    View in: PubMed
    Score: 0.111
  33. Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label study. Eur Child Adolesc Psychiatry. 2009 Aug; 18(8):493-8.
    View in: PubMed
    Score: 0.104
  34. Risperidone treatment for ADHD in children and adolescents with bipolar disorder. Neuropsychiatr Dis Treat. 2008 Feb; 4(1):203-7.
    View in: PubMed
    Score: 0.096
  35. An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS Spectr. 2007 Sep; 12(9):683-9.
    View in: PubMed
    Score: 0.093
  36. A magnetic resonance spectroscopy study of the anterior cingulate cortex in youth with emotional dysregulation. Isr J Psychiatry Relat Sci. 2012; 49(1):62-9.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.